4basebio PLC (AIM:4BB)
480.00
-25.00 (-4.95%)
Apr 28, 2026, 2:56 PM GMT
4basebio Revenue
4basebio had revenue of 1.17M GBP in the half year ending June 30, 2025, with 393.28% growth. This brings the company's revenue in the last twelve months to 1.78M, up 198.49% year-over-year. In the year 2024, 4basebio had annual revenue of 933.00K with 84.39% growth.
Revenue (ttm)
1.78M
Revenue Growth
+198.49%
P/S Ratio
43.94
Revenue / Employee
16.17K
Employees
110
Market Cap
78.16M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Faron Pharmaceuticals Oy | 1.14M |
| Bioventix | 12.54M |
| Ondine Biomedical | 1.18M |
| hVIVO | 49.66M |
| Scancell Holdings | 4.71M |
| ImmuPharma | -69.96K |
| SkinBioTherapeutics | 4.64M |
| Arecor Therapeutics | 1.71M |
4basebio News
- 4 weeks ago - 4basebio Plc - Lease of Manufacturing Facility - Finanz Nachrichten
- 6 weeks ago - 4basebio Plc - Appointment of COO - Finanz Nachrichten
- 2 months ago - 4basebio Plc - Director Dealing - Finanz Nachrichten
- 2 months ago - 4basebio Plc - Leadership Changes - Finanz Nachrichten